Rebecca Sullivan

Rebecca has experience in the development of a diverse range of materials including health technology assessments, advisory boards, global value dossiers, and value propositions. She has worked across a range of therapy areas, including breast cancer, haemophilia, diabetes, and spinal muscular atrophy.

Prior to beginning a career in market access, Rebecca completed an MSci (Hons) in Pharmacology at the University of Glasgow and a PhD in Pharmacokinetics at the University of Manchester in collaboration with AstraZeneca.